Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study

Completed

Conditions studied: Hypertension, Stroke

In brief

The goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes and who are enrolled in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.

Key facts

Study ID
NCT00579306
Run by
Columbia University
People needed
1244
Starts
2005-06-01
Expected to finish
2012-07-01
Last updated by the study team
2017-07-24

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.